Asensus Surgical, Inc. (ASXC)
| Market Cap | 98.68M |
| Revenue (ttm) | 7.22M |
| Net Income (ttm) | -64.25M |
| Shares Out | 236.46M |
| EPS (ttm) | -0.27 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 29,304,259 |
| Open | 0.446 |
| Previous Close | 0.433 |
| Day's Range | 0.400 - 0.459 |
| 52-Week Range | 0.350 - 3.600 |
| Beta | 1.68 |
| Analysts | Buy |
| Price Target | 4.08 (+877.7%) |
| Earnings Date | Aug 4, 2022 |
About ASXC
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up ... [Read more...]
Financial Performance
In 2021, ASXC's revenue was $8.23 million, an increase of 159.28% compared to the previous year's $3.18 million. Losses were -$62.46 million, 5.31% more than in 2020.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for ASXC stock is "Buy." The 12-month stock price forecast is 4.08, which is an increase of 877.71% from the latest price.
News
Asensus Surgical to Participate in the H. C. Wainwright Global Investment Conference
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate...
Asensus Surgical (ASXC) Reports Q1 Loss, Lags Revenue Estimates
Asensus Surgical (ASXC) delivered earnings and revenue surprises of 12.50% and 18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2022
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...
Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 4, 2022
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new er...
Investing in 60 Seconds: Asensus Surgical
Asensus Surgical is leading the digital surgical market with Performance-Guided Surgery(TM)New York, New York--(Newsfile Corp. - April 20, 2022) - PCG Digital -- Surgery can be unpredictable, and a stag...
Asensus Surgical (ASXC) Reports Q4 Loss, Tops Revenue Estimates
Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0% and 7.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2021
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...
Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2021 Financial and Operating Results Conference Call ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new er...
Asensus Surgical: Reimagining the Future of Surgery
Setting a new standard with Performance-Guided SurgeryNew York, New York--(Newsfile Corp. - January 26, 2022) - -- PCG Digital-- Asensus Surgical, Inc. (NYSE American: ASXC) is leading the digital surgi...
Is This Rapidly Growing Surgical Robotics Stock a Buy?
Asensus Surgical's Senhance Surgical System is being more widely adopted by surgeons.
Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...
Best Penny Stocks to Buy In January 2022? 3 Investors Are Watching
Are these penny stocks on your January 2022 watchlist? The post Best Penny Stocks to Buy In January 2022?
Asensus Surgical to Participate in the 40th Annual J.P. Morgan Healthcare Conference and H.C.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive...
Asensus Surgical Announces Purchase of Senhance Robotic System by RZD Medicine
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...
Asensus Surgical Announces Franklin Medical Center to Initiate the Installation of the Senhance Surgical System
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...
Best Biotech Penny Stocks to Buy in November? 3 to Watch Now
Which biotech penny stocks are you watching this month? The post Best Biotech Penny Stocks to Buy in November?
Why Asensus Surgical Stock Is Moving Up Today
Earnings results for the third quarter look great, until you peek under the hood.
Asensus Surgical (ASXC) Reports Q3 Loss, Tops Revenue Estimates
Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0.00% and 152.06%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2021
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...
Asensus Surgical Announces Shinmatsudo Central General Hospital in Japan to Initiate Senhance Robotic Surgical System
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...
Asensus Surgical (ASXC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Asensus Surgical (ASXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 3, 2021
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new er...
Hot Reddit Penny Stocks to Watch Right Now? Check These 3 Out
Reddit penny stocks continue to attract new investors, here's three to watch The post Hot Reddit Penny Stocks to Watch Right Now? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and...
Asensus Surgical, Inc. Announces Hirosaki University Hospital to Initiate Senhance Robotic Surgery Program
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...